UDI Medical Device Unique Identification: Complete NMPA Compliance Guide

UDI (Unique Device Identification) is the medical device full-lifecycle traceability system established by NMPA, aligned with US FDA UDI and EU MDR UDI requirements. As of 2026, NMPA has implemented two batches of UDI catalogs (covering Class III + some Class II devices), with the third batch (covering more Class II + some Class I devices) expected by end of 2026. For medical device manufacturers and import agents, UDI compliance has shifted from a long-term plan to an immediate priority — products without completed UDI filing cannot be legally sold on the market. This article provides a complete operational guide for UDI compliance.

UDI Coding Rules In-Depth. UDI consists of two parts: DI (Device Identifier) and PI (Production Identifier). DI — the static identifier of the device, identifying the registrant/filer and device model. DI is applied from GS1 (or MA Code, AHM, and other NMPA-recognized coding agencies) — one DI per model; model changes require a new DI. PI — the dynamic identifier of the device, identifying production information for each batch/unit. PI may include: lot number (LOT), serial number (SN), manufacturing date (MFG), expiration date (EXP). The DI+PI combination forms a complete UDI, enabling unique identification and traceability of each device or batch. Technical requirements: UDI supports both 1D barcodes (Code128/GS1-128) and 2D codes (QR Code/DataMatrix). DataMatrix QR codes are recommended for medical devices (smaller footprint, suitable for small devices and large data capacity), carrying richer traceability information through the GS1 Digital Link standard.

UDI Implementation Three-Step Strategy. Step 1: DI filing and coding scheme design (1-2 months). Apply for DI number segments from coding agencies, ensuring all marketed device models have corresponding DIs. Determine UDI carrier form (label/direct marking), code type (1D/2D), code position (device body/smallest package/higher-level packaging), and coding process (laser/inkjet/label). NMPA requires UDI carriers to remain readable under normal use and cleaning/disinfection conditions, with durability no less than the device shelf life. Step 2: PI data management and coding system development (2-4 months). Establish PI data management specifications — lot number generation rules, serial number allocation strategy, DI+PI combination logic. Build or upgrade production line coding systems to achieve automatic UDI generation, printing/marking, and collection/association. Simultaneously establish a UDI database ensuring complete traceable records of all factory-shipped UDI data. Step 3: NMPA Unique Device Identification Database filing (conducted in parallel). Complete DI information filing in the NMPA UDI Management Information System — including device identifier, registration certificate information, packaging identifier, storage conditions, clinical specifications, and dozens of other data fields. Filing must be completed before product launch; data changes must be updated within 30 days.

Common Implementation Issues and Avoidance Guide. Issue 1: Inappropriate DI granularity. DI that is too coarse (one DI covering multiple significantly different variants) leads to insufficient traceability precision. DI that is too fine (one DI per minor variant) leads to DI count explosion and management cost spikes. Recommended approach: use registration certificate model as the base granularity, with independent DIs for key specification differences (such as size, material, sterilization status). Issue 2: Direct marking technology selection. For reusable surgical instruments and other products requiring direct marking, laser marking is the most common solution, but attention must be paid to the impact of marking on the device's surface treatment layer and corrosion resistance. Corrosion resistance validation must be performed after marking. Issue 3: Overlooking secondary packaging DI filing. NMPA requires that each packaging level (device body, smallest package, sales unit package, transport package) with different DIs must be filed separately. Many enterprises file only the device DI while omitting packaging DIs. Issue 4: UDI data inconsistency with ERP/registration certificate data. UDI filing data must be completely consistent with product registration certificates, labels, and ERP system product data — any inconsistency in DI filing may be deemed non-compliant during surprise inspections. We recommend establishing a UDI data governance process with the quality and regulatory department performing final review and approval of filing data.

ZhiShuYun UDI Compliance Solution. Our UDI module provides one-stop compliance capabilities: DI Management — helping enterprises standardize DI number segment management, supporting GS1/MA Code/AHM and other coding standards. PI Rules Engine — flexible batch/serial/date combination rule configuration, supporting multiple PI combination modes (LOT+EXP, SN+MFG, etc.). Production Line Coding SDK — seamless integration with laser marking and inkjet equipment, real-time UDI generation and printing for high-speed lines (up to 300 units/minute). UDI Database — automatic recording of all factory-shipped UDI data, supporting automatic export and one-click submission of NMPA database filing data. Compliance Verification — built-in NMPA data validation rules, automatically detecting common issues such as DI duplication and data inconsistency before filing. Whether a single-model small device enterprise or a large medical device group with hundreds of models, UDI compliance systems can be rapidly deployed.